These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33061257)

  • 1. Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease.
    Burade V; Zalawadia R; Patel A; Ogundele A
    Clin Ophthalmol; 2020; 14():2747-2755. PubMed ID: 33061257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
    Strong B; Farley W; Stern ME; Pflugfelder SC
    Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial.
    Rao AT; Gupta A; Chauhan T; Basu S; Batra N; Sharma N; Sangwan VS; Gupta V; Mukherjee S
    BMC Ophthalmol; 2023 Mar; 23(1):121. PubMed ID: 36973703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Controlled Trial Comparing Tearcare
    Ayres BD; Bloomenstein MR; Loh J; Chester T; Saenz B; Echegoyen J; Kannarr SR; Perez VL; Rodriguez TC; Dickerson JE
    Clin Ophthalmol; 2023; 17():3925-3940. PubMed ID: 38143559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis.
    Karpecki P; Barghout V; Schenkel B; Huynh L; Khanal A; Mitchell B; Yenikomshian M; Zanardo E; Matossian C
    BMC Ophthalmol; 2023 Nov; 23(1):443. PubMed ID: 37919692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye.
    Daull P; Feraille L; Barabino S; Cimbolini N; Antonelli S; Mauro V; Garrigue JS
    Exp Eye Res; 2016 Dec; 153():159-164. PubMed ID: 27777121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine inhibits apoptosis in experimental murine xerophthalamia conjunctival epithelium.
    Sun J; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):469-71. PubMed ID: 17120751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.
    Baudouin C; de la Maza MS; Amrane M; Garrigue JS; Ismail D; Figueiredo FC; Leonardi A
    Eur J Ophthalmol; 2017 Nov; 27(6):678-685. PubMed ID: 28708219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye Syndrome.
    Žiniauskaite A; Ragauskas S; Hakkarainen JJ; Rich CC; Baumgartner R; Kalesnykas G; Albers DS; Kaja S
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3088-3093. PubMed ID: 30025146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
    Xiao W; Xu GT; Zhang J; Zhang J; Zhang Y; Ye W
    Exp Eye Res; 2015 Sep; 138():145-52. PubMed ID: 26187517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficiency of Cyclosporine A-Eluting Contact Lenses for the Treatment of Dry Eye.
    Choi JH; Li Y; Jin R; Shrestha T; Choi JS; Lee WJ; Moon MJ; Ju HT; Choi W; Yoon KC
    Curr Eye Res; 2019 May; 44(5):486-496. PubMed ID: 30580651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Switching from Cyclosporine A 0.05% Anionic Emulsion to Cyclosporine A 0.1% Cationic Emulsion in Patients with Dry Eye Associated with Sjögren's Syndrome.
    Kim J; Moon TK; Yoon HJ; Ji YS; Yoon KC
    J Ocul Pharmacol Ther; 2021 Oct; 37(8):472-478. PubMed ID: 34449255
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine Amicellar delivery system for dry eyes.
    Kang H; Cha KH; Cho W; Park J; Park HJ; Sun BK; Hyun SM; Hwang SJ
    Int J Nanomedicine; 2016; 11():2921-33. PubMed ID: 27382280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
    Sall K; Stevenson OD; Mundorf TK; Reis BL
    Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion.
    Turner K; Pflugfelder SC; Ji Z; Feuer WJ; Stern M; Reis BL
    Cornea; 2000 Jul; 19(4):492-6. PubMed ID: 10928765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye.
    Guzey M; Karaman SK; Satici A; Ozardali I; Sezer S; Bozkurt O
    Clin Exp Ophthalmol; 2009 Aug; 37(6):541-9. PubMed ID: 19702702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye.
    Stonecipher KG; Torkildsen GL; Ousler GW; Morris S; Villanueva L; Hollander DA
    Clin Ophthalmol; 2016; 10():887-95. PubMed ID: 27257373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.